Feed:All articles/Pretty: Difference between revisions

Jump to navigation Jump to search

Feed:All articles/Pretty (view source)

Revision as of 08:04, 22 May 2014

28 bytes added ,  22 May 2014
no edit summary
No edit summary
No edit summary
Line 76: Line 76:
         },
         },
         {
         {
             "timestamp" : "2013-11-18T17:32:07Z",
             "timestamp" : "2014-05-22T00:12:34Z",
             "briefDesignDescription" : "ASA/clopidogrel vs. ASA in AF",
             "briefDesignDescription" : "ASA/clopidogrel vs. ASA in AF",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0901301",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0901301",
             "pageid" : 360,
             "pageid" : 360,
             "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0901301",
             "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0901301",
             "trainingLevel" : "Resident",
             "trainingLevel" : "Resident\n}}",
             "citation" : "Connolly SJ, <i>et al</i>. \"Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation\". <i>The New England Journal of Medicine</i>. 2009. 360(20):2066-78.",
             "citation" : "Connolly SJ, <i>et al</i>. \"Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation\". <i>The New England Journal of Medicine</i>. 2009. 360(20):2066-78.",
             "subspecialties" : "Cardiology;Neurology",
             "subspecialties" : "Cardiology;Neurology",
Line 94: Line 94:
         },
         },
         {
         {
             "timestamp" : "2013-08-20T14:04:09Z",
             "timestamp" : "2014-05-22T00:11:27Z",
             "briefDesignDescription" : "ASA/clopidogrel vs. warfarin in AF",
             "briefDesignDescription" : "ASA/clopidogrel vs. warfarin in AF",
             "fulltexturl" : "http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(06)68845-4",
             "fulltexturl" : "http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(06)68845-4",
             "pageid" : 1438,
             "pageid" : 1438,
             "pdfurl" : "http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673606688454.pdf",
             "pdfurl" : "http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673606688454.pdf",
             "trainingLevel" : "Intern",
             "trainingLevel" : "Intern\n}}",
             "citation" : "Connolly SJ, <i>et al</i>. \"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.\". <i>The Lancet</i>. 2006. 367(9526):1903-12.",
             "citation" : "Connolly SJ, <i>et al</i>. \"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.\". <i>The Lancet</i>. 2006. 367(9526):1903-12.",
             "subspecialties" : "Cardiology;Neurology",
             "subspecialties" : "Cardiology;Neurology",
Line 148: Line 148:
         },
         },
         {
         {
             "timestamp" : "2013-10-30T11:32:38Z",
             "timestamp" : "2014-05-22T00:29:37Z",
             "briefDesignDescription" : "Rate vs. rhythm control in AF",
             "briefDesignDescription" : "Rate vs. rhythm control in AF",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa021328",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa021328",
             "pageid" : 87,
             "pageid" : 87,
             "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa021328",
             "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa021328",
             "trainingLevel" : "Student",
             "trainingLevel" : "Student\n}}",
             "citation" : "Wyse DG, <i>et al</i>. \"A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation\". <i>The New England Journal of Medicine</i>. 2002. 347(23):1825-1833.",
             "citation" : "Wyse DG, <i>et al</i>. \"A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation\". <i>The New England Journal of Medicine</i>. 2002. 347(23):1825-1833.",
             "subspecialties" : "Cardiology",
             "subspecialties" : "Cardiology",
Line 292: Line 292:
         },
         },
         {
         {
             "timestamp" : "2013-10-05T21:08:20Z",
             "timestamp" : "2014-05-22T00:06:22Z",
             "briefDesignDescription" : "Apixaban vs. warfarin in AF",
             "briefDesignDescription" : "Apixaban vs. warfarin in AF",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1107039",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1107039",
             "pageid" : 1497,
             "pageid" : 1497,
             "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1107039",
             "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1107039",
             "trainingLevel" : "Intern",
             "trainingLevel" : "Intern\n}}",
             "citation" : "Granger CB, <i>et al</i>. \"Apixaban versus warfarin in patients with atrial fibrillation\". <i>The New England Journal of Medicine</i>. 2011. 365(11):981-982.",
             "citation" : "Granger CB, <i>et al</i>. \"Apixaban versus warfarin in patients with atrial fibrillation\". <i>The New England Journal of Medicine</i>. 2011. 365(11):981-982.",
             "subspecialties" : "Cardiology;Neurology",
             "subspecialties" : "Cardiology;Neurology",
Line 382: Line 382:
         },
         },
         {
         {
             "timestamp" : "2013-10-30T11:09:27Z",
             "timestamp" : "2014-05-22T00:09:20Z",
             "briefDesignDescription" : "Apixaban vs. ASA in AF",
             "briefDesignDescription" : "Apixaban vs. ASA in AF",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1007432",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1007432",
Line 2,362: Line 2,362:
         },
         },
         {
         {
             "timestamp" : "2013-10-30T11:31:37Z",
             "timestamp" : "2014-05-22T00:30:05Z",
             "briefDesignDescription" : "Lenient vs. strict rate control in AF",
             "briefDesignDescription" : "Lenient vs. strict rate control in AF",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1001337",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1001337",
             "pageid" : 181,
             "pageid" : 181,
             "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1001337",
             "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1001337",
             "trainingLevel" : "Resident",
             "trainingLevel" : "Resident\n}}",
             "citation" : "Van Gelder IC, <i>et al</i>. \"Lenient versus Strict Rate Control in Patients with Atrial Fibrillation\". <i>The New England Journal of Medicine</i>. 2010. 362(15):1363-73.",
             "citation" : "Van Gelder IC, <i>et al</i>. \"Lenient versus Strict Rate Control in Patients with Atrial Fibrillation\". <i>The New England Journal of Medicine</i>. 2010. 362(15):1363-73.",
             "subspecialties" : "Cardiology",
             "subspecialties" : "Cardiology",
Line 2,416: Line 2,416:
         },
         },
         {
         {
             "timestamp" : "2013-10-22T10:35:20Z",
             "timestamp" : "2014-05-22T00:10:42Z",
             "briefDesignDescription" : "Dabigatran in mechanical heart valves",
             "briefDesignDescription" : "Dabigatran in mechanical heart valves",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1300615",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1300615",
Line 2,452: Line 2,452:
         },
         },
         {
         {
             "timestamp" : "2014-05-21T23:59:51Z",
             "timestamp" : "2014-05-22T00:04:07Z",
             "briefDesignDescription" : "Dabigatran vs. warfarin in AF",
             "briefDesignDescription" : "Dabigatran vs. warfarin in AF",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0905561",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa0905561",
             "pageid" : 178,
             "pageid" : 178,
             "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0905561",
             "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa0905561",
             "trainingLevel" : "Resident",
             "trainingLevel" : "Resident\n}}",
             "citation" : "Connolly SJ, <i>et al</i>. \"Dabigatran versus warfarin in patients with atrial fibrillation\". <i>The New England Journal of Medicine</i>. 2009. 361(12):1139-51.",
             "citation" : "Connolly SJ, <i>et al</i>. \"Dabigatran versus warfarin in patients with atrial fibrillation\". <i>The New England Journal of Medicine</i>. 2009. 361(12):1139-51.",
             "subspecialties" : "Cardiology",
             "subspecialties" : "Cardiology",
Line 2,560: Line 2,560:
         },
         },
         {
         {
             "timestamp" : "2013-08-20T14:18:59Z",
             "timestamp" : "2014-05-22T00:10:04Z",
             "briefDesignDescription" : "Rivaroxaban vs. warfarin in AF",
             "briefDesignDescription" : "Rivaroxaban vs. warfarin in AF",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1009638",
             "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1009638",
             "pageid" : 1358,
             "pageid" : 1358,
             "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1009638",
             "pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1009638",
             "trainingLevel" : "Student",
             "trainingLevel" : "Student\n}}",
             "citation" : "Patel MR, <i>et al</i>. \"Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation\". <i>The New England Journal of Medicine</i>. 2011. 365(10):883-891.",
             "citation" : "Patel MR, <i>et al</i>. \"Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation\". <i>The New England Journal of Medicine</i>. 2011. 365(10):883-891.",
             "subspecialties" : "Cardiology;Neurology",
             "subspecialties" : "Cardiology;Neurology",
WJCBot
Bots, editor, reviewer, Administrators
13,951

edits

Retrieved from "http://www.wikijournalclub.org/wiki/Special:MobileDiff/12515"

Navigation menu